Can You Give Extra Units of Sliding Scale Insulin?
No, you should not rely on sliding scale insulin alone or give "extra units" as your primary approach—instead, use a scheduled basal-bolus insulin regimen with correction doses as an adjunct, not as monotherapy. 1, 2
Why Sliding Scale Insulin Alone Fails
The American Diabetes Association explicitly states that sole use of sliding scale insulin in the inpatient hospital setting is strongly discouraged. 1 The evidence is clear:
- Sliding scale insulin is a reactive approach that treats hyperglycemia after it has already occurred, leading to rapid blood glucose fluctuations that exacerbate both hyperglycemia and hypoglycemia 1, 2
- Only 38% of patients achieve mean blood glucose <140 mg/dL with sliding scale insulin alone versus 68% with basal-bolus regimens 1, 2
- Meta-analysis of 11 randomized controlled trials (1,322 patients) showed sliding scale insulin provided no benefits in blood glucose control and was associated with significantly increased hyperglycemic events 3
- Sliding scale regimens prescribed on admission are typically used throughout hospitalization without modification, even when control remains poor 1, 2
The Correct Approach: Scheduled Insulin with Correction Doses
Use correction-dose insulin as an important adjunct to scheduled basal-bolus insulin, not as standalone therapy. 1 Here's the proper framework:
For Patients Eating Well:
- Start with total daily dose of 0.3-0.5 units/kg/day 2, 4
- Allocate 50% to basal insulin (once daily) and 50% to rapid-acting prandial insulin (before meals) 2, 4
- Add correction doses of rapid-acting insulin for hyperglycemia 2
For Patients with Poor Oral Intake or NPO:
- Use basal insulin or basal-plus regimen (0.1-0.25 units/kg/day basal insulin) 2
- Add correction doses of rapid-acting insulin every 4-6 hours as needed 1
- Critical: Patients with type 1 diabetes must continue basal insulin even if NPO to prevent diabetic ketoacidosis 1
When Correction Doses Signal a Problem
If correction doses are frequently required, this indicates your scheduled insulin doses are inadequate and must be increased. 1, 2 The correction dose is a dose-finding strategy—not a long-term solution. 1
Limited Acceptable Uses of Sliding Scale Insulin
The American Diabetes Association suggests sliding scale insulin might be acceptable only in these specific scenarios:
- Patients with mild stress hyperglycemia without pre-existing diabetes 2
- Patients with well-controlled diabetes (HbA1c <7%) on minimal home therapy who have mild hyperglycemia during hospitalization 2
- Patients who are NPO with no nutritional replacement and only mild hyperglycemia 2
- Patients who are new to steroids or tapering steroids 2
Safety Considerations
- Basal-bolus regimens carry 4-6 times higher hypoglycemia risk than sliding scale insulin alone (risk ratio 5.75,95% CI 2.79-11.83) 4
- Review and adjust the treatment regimen after any glucose <70 mg/dL 4
- For patients on high home insulin doses (≥0.6 units/kg/day), reduce total daily dose by 20% during hospitalization to prevent hypoglycemia 2, 4
Clinical Evidence
A landmark randomized controlled trial in general surgery patients with type 2 diabetes demonstrated that basal-bolus treatment improved glycemic control and reduced hospital complications (including postoperative wound infections and acute renal failure) compared with sliding scale insulin alone. 1, 4 The pharmacodynamics of rapid-acting insulin aspart show maximum glucose-lowering effect between 1-3 hours after injection with duration of action 3-5 hours, making it appropriate for correction doses when used as part of a comprehensive regimen. 5